Status:
ACTIVE_NOT_RECRUITING
A Study on the Impact of Intelligent Nutrition Management on Clinical Outcomes in Chemotherapy Patients With Gastrointestinal Malignancies
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Conditions:
Gastric (Stomach) Cancer
Esophageal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
An increasing body of evidence suggests that nutritional status is a key factor in determining the quality of life of cancer patients. The sensitivity of cancer patients to anti-tumor treatments, the ...
Eligibility Criteria
Inclusion
- Age ≥ 18 years;
- Voluntarily agree to participate and sign the informed consent form;
- Diagnosed with gastrointestinal malignancy (esophageal cancer, gastric cancer) and planned to undergo chemotherapy;
- Physical activity is acceptable, and capable of undergoing body composition analysis.
Exclusion
- Uncontrolled or severe heart, liver, lung, and kidney diseases;
- History of stroke, epilepsy, or primary brain cancer, or patients with brain metastases from cancer;
- Pregnant individuals;
- Individuals allergic to milk, whey protein, etc.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06997302
Start Date
January 1 2022
End Date
December 31 2025
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China